Using an in vitro drug screen with compounds targeting epigenetic regulators, Leiendecker et al identified an LSD1 inhibitor (LSD1i) as a specific and potent drug impairing the growth of MCV‐positive MCC cell lines in vitro, without affecting the growth of skin fibroblasts. This evidence concerns the gene KDM1A and Merkel cell skin cancer.